The project will address solid tumor resistance to immune checkpoint blockade by decoding metabolic checkpoints that parallel immune ones, thus aiming to restore effector function in exhausted T-cells through targeted metabolic reprogramming.
Author
Carl H. June is Richard W. Vague Professor in Immunotherapy in the Department of Pathology
and Laboratory Medicine at the Perelman School of Medicine of the University of Pennsylvania.